You are here: Industry Insights > obesity

News List

U.S. Kids Are Eating More 'Ultraprocessed' Foods drugs
August 11, 2021
Frozen burgers, pizza pockets and toaster strudel. Energy drinks and sugary sodas. Fruit leather and potato chips. Cookies and cereal bars. Fish sticks and chicken strips.
Type 2 Diabetes in Teens Can Bring Dangerous Complications in 20s drugs
July 30, 2021
Children diagnosed with type 2 diabetes face a high likelihood of developing complications before age 30, a new study suggests.
Obese Men May Have Better Survival With Advanced Prostate Cancer drugs
July 13, 2021
When men have advanced prostate cancer, obesity might offer something of a survival advantage, a preliminary study suggests.
Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Glucagon-like Peptide-1 and Glucagon Receptor Dual Agonist in Overweight or Obese Chinese Participants at the American Diabetes Assoc prnasia
June 25, 2021
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, announces that results of a phase 1 ...
Lumen Bioscience and Novo Nordisk Collaborate on Research of Biologics for Cardiometabolic Disease americanpharmaceuticalreview
June 18, 2021
Lumen Bioscience, a clinical-stage biopharma company developing biologic drugs for prevalent diseases, will collaborate with Novo Nordisk.
Innovent Announces First Overweight or Obese Subject Dosed in A Phase 2 Clinical Trial of IBI362 (a GLP-1 and Glucagon Receptor Dual Agonist) in China prnasia
June 15, 2021
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced that the first ...
AHA News: U.S. Appears to Lose Ground in Controlling High Blood Pressure drugs
June 15, 2021
After years of improvement, high blood pressure control in the U.S. dropped regardless of age, race or ethnicity, according to new research.
Weight-Loss Surgeries Used Least in U.S. States That Need Them Most drugs
June 15, 2021
The American South and Midwest are home to the highest obesity rates in the nation, but a new study reveals that severely obese residents of those regions are the least likely to choose lifesaving weight-loss surgery.
FDA Approves Wegovy (semaglutide) to Treat Adults with Obesity drugs
June 07, 2021
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the new drug application (NDA) for Wegovy™ (semaglutide) injection 2.4 mg, the first-and-only prescription weight-loss medication with once-weekly dosing.
Social & Health Research Center and Quest Diagnostics Team Up to Address Childhood Hunger and Obesity Exacerbated by COVID-19 in Underserved Communities prnewswire
May 25, 2021
Childhood obesity has disproportionately affected Hispanic and Black communities as a result of negative social determinants of health for years.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page